Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Eusa Pharma acquires Asparec rights

Feb. 2, 2012

Impax Pharmaceuticals gains U.S. rights to migraine therapy

Feb. 2, 2012

Shire and Sangamo BioSciences enter agreement for hemophilia therapeutics

Feb. 2, 2012

Astellas and UCB sign Japanese development and commercialization agreement for Cimzia

Feb. 1, 2012

Spectrum Pharmaceuticals in-licenses long-acting granulocyte colony-stimulating factor

Feb. 1, 2012

Takeda returns Posidur rights to Durect

Jan. 31, 2012

Orexo ends collaboration with Janssen

Jan. 31, 2012

Servier and Monash University establish GPCR collaboration

Jan. 31, 2012

Navidea Biopharmaceuticals enters into agreement for Parkinson's disease imaging agent

Jan. 30, 2012

GenVec extends licensing and collaboration agreement with Novartis

Jan. 30, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...